接受高剂量放疗患者的纵向游离DNA低覆盖全基因组测序特征分析
研究对寡转移患者和头颈癌患者在放疗前、中、后六个时间点采集血浆游离DNA,并行低覆盖全基因组测序,另与健康及多转移志愿者血浆样本比较;结果显示拷贝数改变与影像学进展相关,病毒DNA检测可提高低肿瘤分数样本的监测灵敏度。
要点
- 7例多转移癌患者中4例、7例寡转移患者中1例、7例头颈鳞癌患者中1例检出拷贝数改变,这些患者影像显示放疗后进展。
- 无监督学习识别的癌症特异性片段长度特征与基于拷贝数的肿瘤分数估计强相关。
- 4例HPV阳性头颈鳞癌患者样本均检出病毒DNA,可监测极低肿瘤分数样本。
核心结论
- 肿瘤分数升高与肿瘤侵袭性和全身性肿瘤播散相关,该信息可能用于调整治疗策略。
- 通过检测病毒DNA等特定序列,可大幅提高游离DNA测序数据检测癌症的灵敏度。
研究设计与样本
- 收集寡转移患者和头颈鳞癌患者在放疗前、中、后六个时间点的血浆游离DNA,并与健康及多转移志愿者血浆样本比较。
- 对93份血浆游离DNA样本行低覆盖(平均7x)全基因组测序,将拷贝数改变和片段长度分布与临床及影像学发现进行关联。
主要发现
- 7例多转移癌患者中4例、7例寡转移患者中1例、7例头颈鳞癌患者中1例检出拷贝数改变,这些患者影像显示放疗后进展。
- 无监督学习识别的癌症特异性片段长度特征与基于拷贝数的肿瘤分数估计强相关。
- 4例HPV阳性头颈鳞癌患者样本均检出病毒DNA,可监测极低肿瘤分数样本。
临床怎么用
- 作者认为肿瘤分数升高与肿瘤侵袭性和全身性肿瘤播散相关,该信息可能用于调整治疗策略。
- 作者指出通过检测病毒DNA等特定序列可大幅提高游离DNA测序检测癌症的灵敏度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Current radiotherapy guidelines rely heavily on imaging-based monitoring. Liquid biopsy monitoring promises to complement imaging by providing frequent systemic information about the tumor. In particular, cell-free DNA (cfDNA) sequencing offers a tumor-agnostic approach, which lends itself to monitoring heterogeneous cohorts of cancer patients. METHODS: We collected plasma cfDNA from oligometastatic patients (OMD) and head-and-neck cancer patients (SCCHN) at six time points before, during, and after radiotherapy, and compared them to the plasma samples of healthy and polymetastatic volunteers. We performed low-pass (on average 7x) whole-genome sequencing on 93 plasma cfDNA samples and correlated copy number alterations and fragment length distributions to clinical and imaging findings. RESULTS: We observed copy number alterations in 4/7 polymetastatic cancer patients, 1/7 OMD and 1/7 SCCHN patients, these patients' imaging showed progression following radiotherapy. Using unsupervised learning, we identified cancer-specific fragment length features that showed a strong correlation with copy number-based tumor fraction estimates. In 4/4 HPV-positive SCCHN patient samples, we detected viral DNA that enabled the monitoring of very low tumor fraction samples. CONCLUSIONS: Our results indicate that an elevated tumor fraction is associated with tumor aggressiveness and systemic tumor spread. This information may be used to adapt treatment strategies. Further, we show that by detecting specific sequences such as viral DNA, the sensitivity of detecting cancer from cell-free DNA sequencing data can be greatly increased.
引用
- Balázs Z, Balermpas P, Ivanković I, et al. Longitudinal cell-free DNA characterization by low-coverage whole-genome sequencing in patients undergoing high-dose radiotherapy. Radiother Oncol. 2024. PMID: 38834154. doi:10.1016/j.radonc.2024.110364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。